Skip to main content
. 2016 Jun 20;10:1101–1113. doi: 10.2147/PPA.S106311

Table 1.

Attributes and levels included in the scenarios

Attribute Level
Administration method • Subcutaneous self-administration at home
• Intravenous administration by a health care professional at hospital
Risk of adverse events • High risk of adverse events
• Low risk of adverse events
Pain relief and improvement in functional capacity • Pain relief and improvement in functional capacity
• No pain relief and no improvement in functional capacity
Duration of effect (time until perceiving the need for a new dose) • 1 week
• 2 weeks
• 4 weeks
• 8 weeks